Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:3028

Official publication of the Indian Society of Nephrology
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (1,004 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

   Article Figures

 Article Access Statistics
    PDF Downloaded111    
    Comments [Add]    
    Cited by others 1    

Recommend this journal


  Table of Contents  
Year : 2015  |  Volume : 25  |  Issue : 1  |  Page : 61-62

Ceftazidime-induced myoclonus and encephalopathy in hemodialysis patient

Department of Nephrology, SMCSI Medical College, Karakonam, Trivandrum, Kerala, India

Date of Web Publication12-Jan-2015

Correspondence Address:
J Joseph
Department of Nephrology, SMCSI Medical College, Karakonam, Trivandrum, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0971-4065.144426

Rights and Permissions

How to cite this article:
Joseph J, Vimala A. Ceftazidime-induced myoclonus and encephalopathy in hemodialysis patient. Indian J Nephrol 2015;25:61-2

How to cite this URL:
Joseph J, Vimala A. Ceftazidime-induced myoclonus and encephalopathy in hemodialysis patient. Indian J Nephrol [serial online] 2015 [cited 2023 Jan 28];25:61-2. Available from:


A 49-year-old diabetic male on maintenance hemodialysis for 8 months presented with complaints of pain and swelling in the left ear. Investigation revealed hemoglobin of 7.4 g/dl; leukocyte count of 28,400 cells/μL; differential count polymorphs, 86% and lymphocytes, 9%. He was treated with ear packs and oral ciprofloxacin. However, the pain and swelling worsened. Computerized tomography scan of skull showed extensive damage of middle ear and ear ossicles [Figure 1] with skull bone erosions [Figure 2] suggestive of malignant otitis externa. Ceftazidime 1 g twice daily intravenously was added. Considering the potential life- threatening nature of illness, we gave a higher than his renal adjusted dose for ceftazidime. After 2 days of starting ceftazidime, the patient developed myoclonic movements of upper limb and was confused. Since patient was on ciprofloxacin for more than 2 weeks, it was stopped considering it might be contributing to the patient's condition. Magnetic resonance imaging of brain was normal and there was no evidence of extension of infection to brain. He developed generalized myoclonic movements with alteration in sensorium by 4 th day of staring ceftazidime, requiring intensive care support. His myoclonus and encephalopathy was not showing any change in post dialysis period and was present during sleep also. Since his condition was worsening and no other identifiable causative factors were evident in clinical examination, ceftazidime was stopped. Two days later, his movements were reduced and sensorium improved. By 5 th day the patient was fully conscious and myoclonic movements resolved completely. However, he continued to have his ear symptoms and underwent modified radical mastoidectomy. Histology showed granulation tissues. He was continued on ciprofloxacin and was discharged with advice to continue antibiotics for total duration of 3 months. There was no recurrence of myoclonus.

Myoclonus can occur as a side effect of multiple medications. [1] The mechanisms responsible for drug-induced myoclonus is not well understood. [2] Ceftazidime, is a third-generation cephalosporin widely used for the empiric treatment of infection in dialysis patients because of its broad antibacterial spectrum. But cautious adjustment in dosage is imperative for patients with renal insufficiency. [3] The mechanism of neurotoxicity and convulsions caused by cephalosporins involves the inhibition of γ-aminobutyric acid (GABA) binding to GABA receptors. [4] Impairment in active transport of cephalosporins from cerebrospinal fluid to blood due to competitive inhibition by accumulated toxic organic acids in patients with renal failure may account for the susceptibility to neurotoxicity. [5] Drug-induced myoclonus usually resolves after withdrawal of the offending drug. In this patient, the temporal association of the development of myoclonus after starting ceftazidime, and resolution following the discontinuation strongly suggests a causal relationship.
Figure 1: Computed tomography scan skull showing extensive damage of left middle ear and ossicles

Click here to view
Figure 2: Computed tomography skull coronal bone window showing skull base erosion

Click here to view

Due to the uncommon nature of the movement disorders induced by ceftazidime, which is commonly used in dialysis patients closer monitoring is advisable.

  References Top

Gordon MF. Toxin and drug-induced myoclonus. Adv Neurol 2002;89:49-76.  Back to cited text no. 1
Jiménez-Jiménez FJ, Puertas I, de Toledo-Heras M. Drug-induced myoclonus: Frequency, mechanisms and management. CNS Drugs 2004;18:93-104.  Back to cited text no. 2
Slaker RA, Danielson B. Neurotoxicity associated with ceftazidime therapy in geriatric patients with renal dysfunction. Pharmacotherapy 1991;11:351-2.  Back to cited text no. 3
Sugimoto M, Uchida I, Mashimo T, Yamazaki S, Hatano K, Ikeda F, et al. Evidence for the involvement of GABA (A) receptor blockade in convulsions induced by cephalosporins. Neuropharmacology 2003;45:304-14.  Back to cited text no. 4
Richet G, Lopez de Novales E, Verroust P. Drug intoxication and neurological episodes in chronic renal failure. Br Med J 1970;2:394-5.  Back to cited text no. 5


  [Figure 1], [Figure 2]

This article has been cited by
1 Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid
Hiroaki Nishioka, Yojiro Cho, Kei Irie, Maki Kanamori
International Journal of Infectious Diseases. 2022; 116: 223
[Pubmed] | [DOI]


Print this article  Email this article


Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07